NOTE

🌱 created from: palliative_intent-of-hnscc

tpextreme

1.Guigay J, Aupérin A, Fayette J, et al. Cetuximab, docetaxel, and cisplatin versus platinum, fluorouracil, and cetuximab as first-line treatment in patients with recurrent or metastatic head and neck squamous-cell carcinoma (GORTEC 2014-01 TPExtreme): a multicentre, open-label, randomised, phase 2 trial. The Lancet Oncology. 2021;22(4):463-475. doi:10.1016/S1470-2045(20)30755-5